// Workers AI · dad joke modeWhat did Fosun Health say to the germ? "You're insured to lose.
 | |
Native name | 上海复星健康科技（集团）有限公司 |
|---|---|
| Type | Subsidiary |
| Industry | Healthcare |
| Founded | 2010 |
| Headquarters | Shanghai , China |
Area served | Mainland China, Hong Kong, Macau and some overseas markets |
| Products | Hospital operations, specialized medical care, rehabilitation medicine, health management, cross-border medical services |
| Parent | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
| Website | www |
Fosun Health (Chinese: 上海复星健康科技（集团）有限公司) is a Chinese healthcare company headquartered in Shanghai. Established in 2010, it is a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. The company operates hospitals, clinics and diagnostic centres in China and provides cross-border medical services to patients from other Asian markets.[1]
As of 2025, Fosun Health operated 19 hospitals, clinics and third-party diagnostic centres in mainland China. Its principal medical institutions include Foshan Fosun Chancheng Hospital, Guangzhou Fosun Chancheng Hospital, Shenzhen Hengsheng Hospital, Zhuhai Chancheng Hospital, Shanghai Shiguang Plastic Surgery Hospital, Shanghai Xingchen Children's Hospital, Shanghai Zhuoerhui Clinic and Beijing Zhuoerhui Clinic.[2]
History
[edit]Fosun Health was established in Shanghai in 2010 as Fosun Pharma's healthcare services business.[3]
In May 2021, Shanghai Fosun Medical Group was renamed Shanghai Fosun Health Technology (Group) Co., Ltd.[4][5]
In December 2023, Bloomberg reported that Fosun Pharma was considering raising about RMB 1 billion (US$141 million) for Fosun Health and was weighing a potential initial public offering of the hospital business.[6]
In May 2024, Fosun Health raised RMB 300 million from an investment company controlled by the government of Chancheng District in Foshan. The transaction valued Fosun Health at RMB 10.2 billion, and the company committed to pursuing a public listing within five years as part of the investment agreement.[1]
In February 2026, Fosun Health announced plans to establish its first overseas hospitals in Indonesia.[7]
International collaboration
[edit]Fosun Health has expanded its international healthcare network through cross-border medical cooperation, academic exchanges, teleconsultation and partnerships with overseas healthcare institutions.
In January 2026, medical teams from Fosun Health-affiliated hospitals visited Bangladesh for medical consultations and professional exchanges.[8]
In February 2026, Fosun Health announced plans to establish its first overseas hospitals in Indonesia.[7]
In September 2026, Fosun Health hosted the first International Oncology Treatment Forum in Foshan, Guangdong.[9][10] During the forum, Fosun Health launched the Global Oncology Collaboration Alliance and announced cooperation with healthcare institutions in Vietnam, Indonesia, Bangladesh and Central Asia.[11]
Financial performance
[edit]Fosun Health reported revenue of RMB 6.3 billion in 2023, an increase of 2.8% from the previous year, while recording a net loss of RMB 420 million. The company had recorded losses for three consecutive years during the COVID-19 pandemic, compared with a net profit of RMB 1.5 billion in 2019.[1]
Rankings and awards
[edit]In the 2025 edition of the China Hospital Competitiveness Report, Fosun Health ranked second among privately operated hospital groups in China.[12]
In 2026, Fosun Health received the "Oncology Service Provider of the Year in Asia-Pacific" award at the GlobalHealth Asia-Pacific Awards.[13]
References
[edit]- 1 2 3 "Fosun's Hospital Unit Secures $41 Million Funding With IPO Promise - Caixin Global". Caixin Global. Retrieved 2026-08-21.
- ↑ "Unmet healthcare demand in Asia presents Chinese hospitals with opportunities". South China Morning Post. 2025-10-20. Retrieved 2026-08-24.
- ↑ "刘强：社会办医拥有资本优势，决策灵活，执行效率更高". health.people.com.cn. Retrieved 2026-08-21.
- ↑ "威高牵手复星，强强联合领跑这一赛道". 健康界. Retrieved 2026-08-25.
- ↑ "复星医药：不再持有佛山禅曦股权". 财联社. Retrieved 2026-08-25.
- ↑ "Fosun's Hospital Arm Weighs $141 Million Funding Round". Bloomberg. 2023-12-15. Retrieved 2026-08-24.
- 1 2 "Fosun Health to build first overseas hospitals in Indonesia amid global push". South China Morning Post. 2026-02-11. Retrieved 2026-08-21.
- ↑ "China extending medical facilities for Bangladeshi patients through its 'Belt and Road Healthcare Center'". The Financial Express. 2026-01-11. Retrieved 2026-09-28.
- ↑ Qiu, Quanlin (2026-09-23). "Global oncology collaboration platform launched at Foshan forum". China Daily. Retrieved 2026-09-28.
- ↑ "Fosun Health Hosts 1st International Oncology Treatment Forum and Launches Global Complex Case Collaboration Platform". Global Health and Travel. 2026-09-20. Retrieved 2026-09-28.
- ↑ "1st International Oncology Treatment Forum Held in Foshan, as Fosun Health Joins Hands with Experts from Around the World to Build an International Oncology Academic Exchange Platform". Fosun Health. 2026-09-19. Retrieved 2026-09-28.
- ↑ Zhuang, Yiqiang; Liu, Xiande; Yao, Shufang; Zhuo, Jinde; Cai, Hua; Ren, Yaohui (2025). 中国医院竞争力报告（2025） [China Hospital Competitiveness Report (2025)] (in Chinese). Beijing: Social Sciences Academic Press. ISBN 978-7-5228-5306-2.
- ↑ "GlobalHealth Asia-Pacific Healthcare Insights & Leadership Forum 2026 Categories". GlobalHealth Asia-Pacific. 2026. Retrieved 26 August 2026.